BioAge Labs (BIOA) Current Assets (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Current Assets data on file, last reported at $391.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 20.64% year-over-year to $391.9 million; the trailing twelve-month figure through Mar 2026 stood at $391.9 million (up 20.64% YoY), and the FY2025 full-year result was $286.8 million, down 19.69% from the prior year.
• Current Assets advanced to $391.9 million in Q1 2026, from $286.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $391.9 million in Q1 2026 to a low of $25.3 million in Q4 2023.
• A 4-year average of $289.4 million and a median of $313.3 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 1311.14% in 2024 and decreased 19.69% in 2025, its largest moves.
• Tracing BIOA's Current Assets over 4 years: stood at $25.3 million in 2023, then surged by 1311.14% to $357.1 million in 2024, then declined by 19.69% to $286.8 million in 2025, then surged by 36.64% to $391.9 million in 2026.
• Business Quant data shows BIOA's Current Assets at $391.9 million in Q1 2026, $286.8 million in Q4 2025, and $290.8 million in Q3 2025.